Related by context. All words. (Click for frequent words.) 69 hepatitis C virus HCV 69 hepatitis C virus 66 chronic HBV infection 66 HBV 65 Hepatitis C virus 64 chronic HBV 64 hepatitis C HCV 64 Hepatitis B Virus 64 cytomegalovirus CMV 64 Hepatitis C virus HCV 64 Salmonella typhi 64 chronic HCV infection 64 parasite Trypanosoma cruzi 63 Chlamydia trachomatis 63 hepatitis B HBV 63 HBV infection 63 Hepatitis B virus HBV 63 metastatic neuroendocrine tumors 62 HCV infection 62 varicella zoster virus VZV 62 human immunodeficiency virus 62 Helicobacter pylori H. pylori 62 Hepatitis B virus 62 VZV 62 Human papillomavirus HPV 62 replicon 62 HBeAg negative 61 cirrhosis liver failure 61 H. pylori infection 61 CMV infection 61 pneumococci 61 latent tuberculosis infection 61 Escherichia coli Klebsiella pneumoniae 61 Epstein Barr Virus EBV 61 S. aureus infections 61 chemotherapy induced neutropenia 61 chronic HCV 61 hypereosinophilic syndrome 61 CMV disease 60 candidemia 60 cIAI 60 serotype #A 60 H pylori 60 nucleotide analog 60 chlamydial 60 virus HCV infection 60 Genital herpes 60 Human papilloma virus 60 hepatitis B virus 60 hepatitis B infection 60 S. aureus 60 Epstein Barr virus EBV 59 Streptococcus pyogenes 59 bacterium Neisseria meningitidis 59 Cholangiocarcinoma 59 N. meningitidis 59 S. aureus bacteria 59 mycobacterium tuberculosis 59 virus HBV 59 chronic hepatitis B. 59 H. pylori 59 genital herpes infections 59 methicillin resistant S. aureus 59 methicillin susceptible Staphylococcus aureus 59 Staphylococcus aureus MRSA 59 pneumococcal infection 59 Streptococcus pneumoniae pneumococcus 59 chronic hepatitis C 59 HCV infections 59 HCV 59 Candida species 59 N. gonorrhoeae 59 coinfection 59 vaccine serotypes 59 varicella zoster virus 59 Respiratory Syncytial Virus RSV 58 dengue viruses 58 refractory gout 58 Hepatitis C Virus HCV 58 investigational monoclonal antibody 58 TTR gene 58 pneumococcal pneumonia 58 discontinued Viread 58 Staphylococcus aureus infections 58 clade B 58 C. trachomatis 58 methicillin sensitive 58 cytomegalovirus infection 58 simian foamy virus 58 invasive aspergillosis 58 hepatitis C genotype 58 nonvaccine serotypes 58 Neisseria gonorrhoeae 58 inhibit replication 58 herpes zoster shingles 58 MDR tuberculosis 58 genital ulcer disease 58 rotaviruses 58 Bordetella pertussis 58 fluoroquinolone resistance 58 S. pneumoniae 58 HBsAg 58 Chlamydia pneumoniae 58 hepatocellular carcinoma 58 Neisseria meningitidis 58 iron overload 58 herpes simplex virus 58 Human Papilloma Virus 58 HIV coinfected 58 vWD 58 CCR5 tropic HIV 58 S. aureus infection 58 Candida infections 58 Candida albicans 58 Plasmodium parasite 58 P. aeruginosa 58 Telbivudine 58 penicillin resistant Streptococcus 58 decompensated liver disease 58 severe rotavirus gastroenteritis 57 Typhi 57 Amgen Neulasta R 57 Haemophilus influenza 57 invasive candidiasis 57 immunosuppressed patients 57 anal HPV 57 Chronic Hepatitis B 57 cytomegalovirus 57 methicillin resistant MRSA 57 protein tyrosine phosphatase 1B 57 chronic granulomatous disease 57 Ribavirin causes 57 chlamydial infection 57 Candida infection 57 cSSSIs 57 carbapenem resistant 57 LTBI 57 enterotoxigenic E. coli 57 CD8 responses 57 K ras mutations 57 S. pyogenes 57 recombinant hepatitis B 57 Human papillomavirus 57 CTAP# Capsules 57 JAK2 enzyme 57 Kaposi sarcoma 57 grade cervical intraepithelial 57 Trichomonas vaginalis 57 herpes zoster virus 57 vaginal candidiasis 57 Hepatitis C HCV 57 ADPKD 57 Streptococcus pneumoniae Haemophilus influenzae 57 Cryptococcus neoformans 57 viral subtypes 57 cryptococcosis 57 Clostridium difficile infection 57 simplex virus 57 lipohypertrophy 57 H. influenzae 57 S.aureus 57 NS5b 57 herpes zoster 57 chronic hepatitis B 57 HPV# 57 effector function 57 HPV subtypes 57 Mycobacterium tuberculosis 57 S aureus 57 asymptomatic carriers 57 Plasmodium vivax 57 NRTI resistance 57 chronic HCV genotype 57 immunocompromised patients 57 RG# nucleoside analog 57 vaginal cancers 56 Kit CD# positive 56 chemokine receptors 56 latent TB infection 56 T. cruzi 56 Multidrug resistant 56 chronic hepatitis 56 cervical neoplasia 56 leukemia ALL 56 chronic eosinophilic leukemia 56 TYZEKA 56 Clostridium difficile infections 56 NS4A 56 bacterium Chlamydia trachomatis 56 COPEGUS ribavirin 56 novel VDA molecule 56 oncogenic HPV 56 mycobacterium 56 HCV polymerase 56 Streptococcus pneumoniae 56 grade cervical dysplasia 56 multidrug resistance 56 Hib meningitis 56 Enterobacter cloacae 56 hepatitis B 56 invasive fungal infections 56 TB bacterium 56 BMPR2 56 CMV infections 56 Dengue virus 56 immunocompetent 56 S. aureus bacteremia 56 Lupus nephritis 56 multidrug resistant 56 HCV NS3 protease 56 precursor lesions 56 opportunistic pathogens 56 S. suis 56 Epidermal Growth Factor Receptor 56 HCV genotypes 56 recurrent genital herpes 56 Daclizumab 56 streptococcus bacterium 56 pneumococcus 56 secondary hyperparathyroidism 56 Herpes simplex virus 56 vancomycin resistant 56 HIV infection 56 HuLuc# 56 telbivudine 56 FOLOTYN ® 56 allogeneic bone marrow 56 AIDS Acquired Immune 56 bacteria Streptococcus pneumoniae 56 CD3 monoclonal antibody 56 hemagglutination inhibition 56 hyperphenylalaninemia HPA due 56 surface antigen HBsAg 56 CCR5 antagonist 56 serogroup B 56 CMV retinitis 56 kidney urologic 56 Vancomycin resistant 56 quinolone resistant 56 bacterium Streptococcus 56 cervical intraepithelial neoplasia 56 Lymphocytic 56 Shiga toxin producing 56 Viread tenofovir disoproxil fumarate 56 Tyzeka 56 Chlamydia trachomatis infection 56 genus Plasmodium 55 M#V mutation 55 Chronic hepatitis B 55 genital ulcers 55 systemic fungal infections 55 posterior uveitis 55 gastric adenocarcinoma 55 Pseudomonas aeruginosa infections 55 combination antiretroviral therapy 55 methicillin resistance 55 hepatoma 55 b Hib 55 pneumococcal bacteria 55 bacteria Pseudomonas 55 Enterococcus faecium 55 Leishmania parasite 55 breast carcinomas 55 vancomycin resistant enterococci VRE 55 CDAD 55 IgG antibodies 55 enterococcal 55 acute GvHD 55 diarrhea CDAD 55 basiliximab 55 Human Papilloma Virus HPV 55 coagulase negative staphylococci 55 serogroup 55 Cytotoxic T 55 methicillin susceptible 55 Salmonella Typhi 55 B CLL 55 lymphoma CTCL 55 Dacetuzumab 55 helicobacter pylori 55 serogroup C 55 Helicobacter pylori 55 chancroid 55 epithelial tumors 55 disease CDAD 55 S. aureus colonization 55 HbF 55 TB MDR TB 55 Shiga toxin 55 severe oral mucositis 55 elevated triglyceride levels 55 sustained virologic response 55 Plasmodium ovale 55 Pseudomonas aeruginosa bacterium 55 fungal organisms 55 LRP5 55 Acute Bacterial Sinusitis ABS 55 Cytomegalovirus CMV 55 SSc 55 superinfection 55 ano genital warts 55 neuroblastoma tumors 55 Trypanosoma brucei 55 investigational integrase inhibitor 55 infections cIAI 55 Borrelia 55 AEG# 55 human papillomavirus HPV 55 Chlamydia infection 55 protease inhibitors PIs 55 bacteria Mycobacterium tuberculosis 55 coinfections 55 HER2 overexpression 55 resistant microorganisms 55 Acute Bacterial Skin 55 P aeruginosa 55 Neisseria meningitidis serogroups 55 BARACLUDE ® 55 nonnucleoside reverse transcriptase inhibitors 55 AmBisome 55 systemic lupus erythematosus SLE 55 including thyroiditis RA 55 CYT# potent vascular disrupting 55 staphylococcal 55 TNFa 55 LCMV infection 55 Haemophilus influenzae 55 T1DM 55 purpura ITP 55 cervical vaginal 55 Fibroblast Growth Factor Receptor 55 nasal carriage 55 Mycoplasma pneumoniae 55 Leukemias 55 Propionibacterium acnes 55 minimally symptomatic metastatic castrate 55 BRAF mutation 55 chlamydial infections 55 Sebivo 55 CCR5 receptor antagonist 55 cervical vulvar 55 Nilotinib 55 Chronic HCV infection 55 P. falciparum malaria 55 Boceprevir 55 e antigen HBeAg 55 urethritis 55 idiopathic thrombocytopenic purpura ITP 55 NS#/#A protease 55 Naive Patients 55 MyVax R 55 virus XMRV 55 adefovir 55 ceftazidime 55 hepatocellular carcinoma HCC 55 Onychomycosis 55 necrotizing pancreatitis 55 pneumococcal infections 55 humanized monoclonal antibody 55 protease inhibitor PI 55 Omacetaxine 55 Herpes Simplex Virus 55 MRSA colonization 55 chronic immune thrombocytopenic 55 serologic 55 invasive pneumococcal disease 55 hepatocellular cancer 55 receiving immunosuppressive therapy 55 orally administered inhibitor 55 chronically infected 55 ABSSSI 55 Vesivirus 55 dermatophytes 55 Mycobacterium tuberculosis TB 55 basal cell nevus syndrome 55 C. jejuni 55 perinatal transmission 55 rotavirus diarrhea 55 serogroups 55 Hepatitis B Hepatitis C 55 plague bacterium Yersinia 55 M. leprae 54 Moraxella catarrhalis 54 Plasmodium falciparum malaria 54 posaconazole 54 Elvitegravir 54 latent tuberculosis 54 systemic scleroderma 54 tumor metastases 54 gastric carcinoma 54 Staphylococcus aureus S. aureus 54 causes chickenpox 54 Extensively drug 54 viral pathogens 54 BRAF gene 54 myelofibrosis polycythemia vera 54 sodium glucose cotransporter 54 Janus kinase 54 refractory chronic lymphocytic 54 esophageal candidiasis 54 protozoan parasite 54 protease inhibitor mutations 54 castrate resistant prostate cancer 54 bacterial vaginosis BV 54 Cytomegalovirus 54 zidovudine AZT 54 acute myelogenous leukemia AML 54 Familial Adenomatous Polyposis FAP 54 Helicobacter 54 Enzastaurin 54 nucleoside analog 54 vidofludimus 54 nucleoside analogues 54 Clevudine 54 gonococcal infections 54 CCR5 delta# 54 nasopharyngeal carcinoma 54 measles virus 54 Squamous 54 venous thromboembolic events 54 MALT lymphoma 54 Human Papillomavirus HPV 54 intestinal mucosa 54 Herpes virus 54 AA Amyloidosis 54 CD# monoclonal antibody 54 Sudhir Agrawal D.Phil 54 naive HCV 54 transgenic rats 54 selective modulator 54 tigecycline 54 voriconazole 54 Glioblastoma multiforme GBM 54 Chronic Hepatitis C 54 H. pylori bacteria 54 prostate cancer CaP 54 MDRSP 54 external genital lesions 54 amebiasis 54 Streptococcus pneumonia 54 CHIKV 54 bacterium Mycobacterium tuberculosis 54 Alinia 54 Schistosomiasis 54 squamous cell lung cancer 54 Streptococcus agalactiae 54 gastrointestinal stromal tumors GISTs 54 immunocompromised individuals 54 oral prodrug 54 S Typhi 54 sexually transmitted HPV 54 humanized antibody 54 include Healive 54 Hepatitis C Virus 54 Plasmodium falciparum 54 HCV genotype 1 54 falciparum 54 Carcinoid tumors 54 delta isoform 54 HIV1 54 Recombinant interferon alpha 54 seronegative 54 M.tb 54 non metastatic osteosarcoma 54 M. pneumoniae 54 Entamoeba histolytica 54 chlamydia infection 54 cervical cancer genital warts 54 Respiratory syncytial virus 54 Borrelia burgdorferi 54 daptomycin 54 FVIII inhibitors 54 Poliovirus 54 Human Papillomavirus 54 associated lymphoid tissue 54 foodborne infections 54 Hepatitis B HBV 54 Cethromycin 54 apolipoprotein E4 54 Chronic myeloid leukemia CML 54 Valcyte 54 pediatric acute lymphoblastic 54 Shigella bacteria 54 WT1 54 Staphylococcus aureus 54 bacterial sepsis 54 EBV infection 54 Chemokine Receptor 54 pneumococcal illnesses 54 Severe Primary IGFD 54 H.pylori 54 T#I mutant 54 herpesviruses 54 monoclonal 54 Respiratory syncytial virus RSV 54 necrotizing pneumonia 54 UGT#A# 54 nosocomial hospital 54 IgG antibody 54 diarrhea abdominal cramps nausea 54 ocular infections 54 liver decompensation 54 severe malignant osteopetrosis 54 Bilive R combined 54 Apaziquone 54 myeloproliferative neoplasms 54 IgA antibodies 54 Helicobacter pylori infection 54 Trypanosoma cruzi 54 HPV-#/# 54 PRTX 54 polymerase inhibitors 54 idiopathic pulmonary fibrosis IPF 54 diarrhea BVD 54 candidiasis 54 Adjuvanted 54 pestis 54 pharyngitis tonsillitis 54 R5 tropic 54 K#N 54 Shigella 54 antibody MAb 54 nucleoside naive 54 pneumoniae 54 CD4 + T lymphocytes 54 humanized monoclonal antibodies 54 BARACLUDE R 54 AAT deficiency 54 P. vivax malaria 54 Systemic lupus erythematosus SLE 54 highly immunogenic 54 NOMID 54 Epratuzumab 54 reinfection 54 Blinatumomab 54 CA MRSA infections 54 T. pallidum 54 causative organism 54 gastrointestinal mucositis 54 relapsed MM 54 ovarian breast 54 Entecavir 54 HPV genotypes 54 sJIA 54 nucleotide analogue 54 cutaneous T 54 Bacteremia 54 Varicella Zoster 54 Viral Load 54 Acute myeloid leukemia 54 human rhinovirus HRV 54 hematologic disorders 54 HIV coinfection 54 methylated DNA 54 Pralatrexate 54 Herpes zoster 54 staphylococci 54 Anopheles gambiae mosquitoes 54 nosocomial infection 54 adenoviral 54 MYH9 gene 54 acute promyelocytic leukemia APL 54 Chronic lymphocytic leukemia 54 VivaGel TM 54 oral squamous cell 54 type 1diabetes 54 Klebsiella pneumoniae 54 sustained virological response 53 erlotinib Tarceva ® 53 targeting CD# 53 staphylococcal infections 53 polio hepatitis B 53 Pulmonary arterial hypertension 53 deep venous thromboses 53 lymphoid tumors 53 Virus Infection 53 lymphocytic choriomeningitis virus LCMV 53 Gilead Viread 53 FLT3 53 methicillin resistant 53 efavirenz emtricitabine 53 Hib disease 53 CXCR4 53 drugs isoniazid 53 transcriptase inhibitors 53 SPRYCEL ® 53 tumor antigen 53 HBV infections 53 nonsense mutations 53 staphylococcus bacteria 53 TTR amyloidosis 53 Natalizumab 53 Clostridium difficile associated 53 acid phosphatase PAP 53 huC# DM4 53 HeFH 53 nonvaccine 53 myeloproliferative disorders 53 MyVax ® 53 HER2 gene 53 Fabry Disease 53 E. coli STEC 53 DAS# [001] 53 nucleoside analogue 53 Gleevec resistant 53 parasite Plasmodium falciparum 53 enteroviruses 53 naive HCV genotype 53 Syndrome HARS 53 Histoplasma capsulatum 53 immuno compromised individuals 53 resistant Staphylococcus aureus 53 genital human papillomavirus 53 ALN TTR 53 herpes simplex viruses 53 SEBIVO 53 variant allele 53 PAOD 53 human metapneumovirus 53 Chronic hepatitis C 53 imatinib Gleevec 53 Conjugate Vaccine 53 Simian Immunodeficiency Virus 53 Acute Myeloid Leukemia AML 53 papillary renal cell carcinoma 53 cutaneous T cell 53 Hereditary angioedema HAE 53 HAV infection 53 VEGF receptor 53 KRAS mutation 53 solithromycin 53 treatment naïve genotype 53 cirrhosis liver cancer 53 bacteraemia 53 skeletal metastases 53 non nucleoside reverse 53 bacterial respiratory infections 53 chronic hepatitis C. 53 cervical lesions 53 HTS assay 53 Thiovir 53 signal transduction inhibitors 53 genital lesions 53 chemokine receptor 53 C trachomatis 53 papillomaviruses 53 allogeneic HSCT 53 Duchenne muscular dystrophy DMD 53 AA amyloidosis 53 E. histolytica 53 parasite Plasmodium 53 valent pneumococcal conjugate vaccine 53 vancomycin resistant Staphylococcus aureus 53 ketolide antibiotic 53 adenovirus infection 53 prophylactic vaccine 53 Fungal Infections 53 evaluating tivozanib 53 thymalfasin 53 HCMV 53 Raltegravir 53 myelodysplastic myeloproliferative diseases 53 attenuated strain 53 parasite transmitted 53 colorectal cancer CRC 53 anal cancers 53 chronically immunosuppressed solid 53 Plasmodium falciparum parasite 53 Methicillin 53 viremia 53 Exelixis XL# 53 RhD 53 mesenchymal cell 53 leukemia CLL 53 herpes simplex 53 Vaccine Candidate 53 TAT2 53 precancerous cervical 53 KIF6 gene 53 JAK inhibitor 53 diabetic kidney 53 immune idiopathic thrombocytopenic 53 single celled parasite 53 human herpesvirus 53 oral JAK1 53 lymphogranuloma venereum 53 NY ESO 53 Sustiva efavirenz 53 coagulase negative 53 chickenpox varicella 53 tipranavir ritonavir 53 HBeAg positive 53 cytopathic 53 hepatitis C viral infection 53 CDDO Im 53 oral poliovirus 53 HER2 expression 53 oesophageal adenocarcinoma 53 Candidiasis 53 Malignant Melanoma 53 Pneumocystis 53 bacteria Neisseria meningitidis 53 oral ghrelin agonist 53 relapsed leukemia 53 colorectal carcinoma 53 Opportunistic infections 53 Varicella zoster virus 53 trimethoprim sulfamethoxazole 53 EGFR inhibitors 53 PCV7 vaccine 53 severe hepatomegaly 53 phenylketonuria PKU 53 familial hypercholesterolemia 53 fluoroquinolone antibiotic 53 atypical hemolytic uremic syndrome 53 Babesia 53 precancerous cervical lesions 53 Chlamydia infections 53 HCV infected 53 PREVNAR 53 intestinal infections 53 herpes zoster vaccine 53 HCV replicon 53 murine leukemia virus 53 Dapagliflozin 53 osteosarcomas 53 chronic Hepatitis B 53 Alferon LDO 53 USA# strain 53 GABHS 53 latently infected 53 TB bacillus 53 pentostatin 53 DU #b 53 Trypanosoma 53 granzyme B 53 seropositivity 53 P. acnes 53 mitochondrial toxicity 53 MenB 53 HCD# [002] 53 BCG vaccinated 53 HSV2 53 Therapeutic Vaccine 53 CCX# 53 telaprevir VX 53 Moraxella bovis 53 DENV 53 noninfectious uveitis 53 hereditary hemochromatosis 53 cholangiocarcinoma 53 virus HCV 53 toenail onychomycosis 53 HepaGam B TM 53 adalimumab Humira 53 Burkholderia pseudomallei 53 Schistosoma 53 AGHD 53 genotype 1b 53 SHPT 53 Fludase 53 hypoparathyroidism 53 Vidofludimus 53 HspE7 53 Pneumococcus 53 human papilloma viruses 53 LHRH antagonists 53 Antibiotic resistant infections 53 Ebola Marburg 53 viral hemorrhagic fevers 53 lung fibrosis 53 wart virus 53 Denufosol 53 leukaemias 53 transfusion transmitted 53 Skin Structure Infections ABSSSI 53 GISTs 53 bacterial pathogen 53 Dengue Virus 53 dasatinib Sprycel 53 nosocomial pneumonia 53 renal cell carcinomas 53 Evoltra ® 53 H.I.V. 53 diphtheria pertussis 53 Bezielle 53 contagious bacterial infection 53 glucokinase activators 53 bacterium Streptococcus pneumoniae 53 recurrent glioma 53 JAK2 V#F 53 smoldering multiple myeloma 53 monoclonal antibody MAb 53 p# biomarker 53 CEQ# 53 Tofacitinib 53 relapsed ALL 53 germline mutation 53 virology Progenics 53 HSV1 53 CCR5 tropic 53 Acute Radiation Syndrome ARS 53 Helicobacter Pylori 53 oral herpes 53 Genital HPV 52 genital sores 52 HIV serostatus 52 erythromycin resistant 52 prevalent sexually transmitted 52 Hp2 2 52 Treg cell 52 vancomycin resistant enterococci 52 parainfluenza virus 52 alpha interferons 52 syngeneic 52 cryptococcal meningitis 52 Oritavancin 52 Beta thalassemia 52 refractory chronic myeloid 52 virus AAV 52 respiratory viral infections 52 PRT# 52 Staph Aureus 52 hepatitis C infection 52 intrauterine infection 52 gastric carcinogenesis 52 wild poliovirus 52 malaria parasites 52 pathogenic bacterium 52 PCNSL 52 MRSA bacterium 52 latent TB 52 pancreatic islet 52 latent infection 52 PNP inhibitor 52 herpes infections 52 GCase 52 anti CD3 52 F#del mutation 52 neuroendocrine cancers 52 S. aureus isolates 52 plasmodium parasite 52 mRCC 52 GNAQ 52 C1 INH deficiency 52 conjugate vaccine 52 nanoviricides ® 52 Severe acute exacerbations 52 adenovirus vector 52 invasive pneumococcal 52 GRNOPC1 contains 52 sleeping sickness trypanosomiasis 52 huntingtin gene 52 proteasome inhibitor 52 ANCA associated 52 human papillomaviruses HPV 52 etiologic agent 52 MYDICAR ® 52 bacteremic pneumonia 52 Adhibit 52 Antibiotic resistant 52 Vacc 4x 52 snail fever 52 polycythemia vera PV 52 reduce serum phosphate 52 liver scarring 52 Etravirine 52 acute leukemia AML 52 rheumatoid arthritis Crohn disease 52 Pneumocystis pneumonia PCP 52 refractory prostate cancer 52 Staphylococcus bacteria 52 orchitis 52 varicella chickenpox 52 relapsing remitting MS RRMS 52 Allovectin 7 R 52 transcriptase inhibitors NNRTIs 52 1 diabetes T1D 52 nitazoxanide 52 streptococcus pneumoniae 52 Epstein Barr virus 52 hyperplasia BPH 52 immunodeficiency 52 Diabetic Macular Edema 52 JAK2 mutation 52 helminth infections 52 Human immunodeficiency virus 52 glucocorticoid induced osteoporosis 52 shingles herpes zoster 52 Plasmodium parasites 52 Neulasta ® 52 penile cancers 52 ® emtricitabine 52 non nucleoside HCV 52 cell lymphoma CTCL 52 Hepsera 52 tumors GIST 52 bacteremia 52 cancerdefine 52 Staphylococci 52 Hepatitis B 52 A3 adenosine receptor 52 CLL cells 52 genital HSV 52 influenza subtypes 52 opportunistic pathogen 52 M. bovis 52 cytomegalovirus CMV retinitis 52 immunomodulator 52 TNF blockers 52 tyrosine kinase inhibitor 52 viral tropism 52 pneumocystis pneumonia 52 ganciclovir 52 Genital Herpes 52 juvenile idiopathic arthritis JIA 52 papilloma virus 52 Tavocept 52 Chronic lymphocytic leukemia CLL 52 Aortic stenosis 52 superficial bladder cancer 52 Chlamydophila pneumoniae 52 MRSA isolates 52 gastroenteritis conjunctivitis 52 bacterial conjunctivitis 52 Paratuberculosis para TB 52 CCR9 antagonist 52 endometriosis ovarian cysts 52 Idiopathic pulmonary fibrosis 52 reverse transcriptase inhibitors 52 cervical HPV 52 Pseudomonas aeruginosa 52 Ebola virus infection 52 pDCs 52 Herpes Simplex 52 congenital ichthyosis 52 oropharyngeal candidiasis OPC 52 chronic ITP 52 Azedra 52 transthyretin amyloidosis 52 neutralizing antibodies 52 RNAi therapeutic targeting 52 Idiopathic Thrombocytopenic Purpura ITP 52 humanized anti 52 efalizumab 52 bone metastasis 52 chlamydia trachomatis 52 live attenuated influenza 52 ASCUS 52 Peptide YY 52 brivanib 52 malarial parasite 52 heterosexually acquired 52 AAV2 52 metastatic malignant 52 RSV infections 52 fatal hemorrhagic 52 vaginitis 52 Oncogenic 52 Shigatoxin producing E. coli 52 haematologic malignancies 52 dose intramuscular 52 HIV infected 52 oral JAK#/JAK# inhibitor 52 meningococcus 52 CIMZIA ™ 52 transcriptase inhibitor NNRTI 52 P. gingivalis 52 CCR5 co 52 medulloblastomas 52 protozoal 52 Escherichia coli O# 52 genital ulcer 52 nonsense mutation 52 leukemia AML 52 P. falciparum 52 diphtheria whooping cough tetanus 52 gastrointestinal stromal tumors GIST 52 Clostridium difficile Infection 52 MTHFR 52 terlipressin 52 Myelodysplastic syndromes 52 MenACWY 52 meningitides 52 PTLD 52 alphavirus 52 P. aeruginosa infections 52 HPV Human Papillomavirus 52 epithelial ovarian 52 E7 proteins 52 Plasmodium 52 Heterozygous Familial Hypercholesterolemia 52 hepatorenal syndrome 52 MDR Gram negative 52 pDC 52 ImmunoVEX HSV2 52 IgM antibodies 52 Advanced Melanoma 52 2 diabetes T2D